The mind shrinkage noticed in Alzheimer’s could also be prevented by semaglutide, the drug in Ozempic
ZEPHYR/Science Picture Library/Alamy
Ozempic and Wegovy are already reworking how we deal with sort 2 diabetes and weight problems, and from subsequent yr one other situation affecting tens of millions of individuals worldwide is likely to be added to the listing: Alzheimer’s illness.
Two medical trials investigating semaglutide, the drug in Ozempic and Wegovy, as a remedy for early Alzheimer’s are anticipated to conclude in 2025. If the outcomes are optimistic, it might mark a breakthrough in treating this intractable situation.
